Merck , known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two...
Read morePfizer Inc and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the...
Read moreLAU-7b has shown potent antiviral effects against SARS-CoV-2 and MERS-CoV coronaviruses, and is also being developed for its anti-inflammatory properties....
Read moreNovavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the first volunteers have...
Read moreCPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a...
Read moreQ BioMed Inc., a commercial-stage biotech company, said that with its technology partner, Mannin Research, a GMP production contract has...
Read moreDaiichi Sankyo Company announced that it has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo’s...
Read moreKite, a Gilead Company announced that the U.S. FDA has granted accelerated approval to Tecartusâ„¢ (brexucabtagene autoleucel, formerly KTE-X19), the...
Read moreGlenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to...
Read moreThe United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.